Funding for this research was provided by:
Received: 28 June 2019
Accepted: 5 March 2020
First Online: 30 March 2020
Compliance with ethical standards
: OS, RL and GO are employed by Quantify Research, which has received consultancy fees from several pharmaceutical companies marketing osteoporosis drugs. KÅ has received lecture and consultancy fees from Amgen, UCB, Merck, Sandoz, Renapharma, and Eli Lilly. AS has received lecture fees from Amgen, Mylan and Eli Lilly. JO is employed by Amgen and is an Amgen stock owner. ÖL has no conflict of interest.